Nektar Reports Durable Hair Regrowth With REZPEG, Phase III Alopecia Trial Next
Nektar says REZPEG produced durable hair regrowth in alopecia patients, and the data set up a Phase III trial of the candidate in the autoimmune hair-loss indication.
Topic
Phase Iii Trial
Topic